Mantis Biotechnology
San Francisco, US · Founded 2025 · Delaware corporation
Founders & leadership
GW
Georgia WitchelNamed on SEC filing
Board
JL
Jessica LeaoBoard director
Reported raises · per SEC filings
Form D private placements$4.8M disclosed across 1 round · 2025
▶$4.8MraisedDec 2025 · 5 investors · BiotechnologyRule 506(b)
▶$4.8MraisedDec 2025 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jessica LeaoDirector
- Georgia WitchelExecutive Officer, Director, Promoter
- Offering amount
- $5.5M
- Amount sold
- $4.8M
- First sale
- Nov 2025
- Incorporated
- Corporation, Delaware, 2025
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Mantis Biotechnology raised?
- Mantis Biotechnology has disclosed $4.8M raised across 1 round.
- Where is Mantis Biotechnology headquartered?
- Mantis Biotechnology is headquartered in San Francisco, US.